Press releases
Some non-regulatory announcements are only available in English. All announcements required under applicable law, regulation or code are available in English and Swedish.
2026
24 Sep 2026, 07:00 | Regulatory
22 Sep 2026, 17:30 | Regulatory
21 Sep 2026, 17:15
27 Aug 2026, 18:45
21 Aug 2026, 07:30 | Regulatory
Lund, Sweden August 21, 2026, Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office in Lund, gives notice to Extraordinary General Meeting to be held on September 22, 2026 at 15.00 CEST at Hansa Biopharma’s office on Scheelevägen 22, SE-223 63 Lund. Registration starts at 14.30 CEST.
21 Aug 2026, 07:00 | Regulatory
18 Aug 2026, 08:00
22 Jul 2026, 07:00 | Regulatory
· €115 million out-licensing agreement
· Positive data from European confirmatory trial (PAES)